These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 30694010

  • 1. Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.
    Schlabe S, van Bremen K, Goldmann G, Oldenburg J, Eis-Hübinger AM, Zeitler H, Spengler U.
    Haemophilia; 2019 Mar; 25(2):e117-e120. PubMed ID: 30694010
    [No Abstract] [Full Text] [Related]

  • 2. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM, Berntorp E.
    Prog Clin Biol Res; 1990 Mar; 324():69-78. PubMed ID: 2106694
    [No Abstract] [Full Text] [Related]

  • 3. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
    Berntorp E, Astermark J, Carlborg E.
    Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
    [Abstract] [Full Text] [Related]

  • 4. The management of hemophilia patients with inhibitors.
    Nilsson IM.
    Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
    [No Abstract] [Full Text] [Related]

  • 5. Regimens of factor VIII administration--continuous infusion vs. bolus.
    Berntorp E.
    Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
    [Abstract] [Full Text] [Related]

  • 6. Induced immunotolerance in factor VIII inhibitor patients.
    Brackmann HH.
    Prog Clin Biol Res; 1984 Oct; 150():181-95. PubMed ID: 6431426
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitors in haemophilia: a primer.
    DiMichele DM.
    Haemophilia; 2000 Jul; 6 Suppl 1():38-40. PubMed ID: 10982266
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U.
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B.
    Dev Biol (Basel); 2003 Aug; 112():55-9. PubMed ID: 12762504
    [Abstract] [Full Text] [Related]

  • 10. [Hemophilia, a changed picture].
    Breederveld C, ten Cate JW, Sixma JJ, Veltkamp JJ.
    Ned Tijdschr Geneeskd; 1976 Jan 10; 120(2):69-70. PubMed ID: 1250448
    [No Abstract] [Full Text] [Related]

  • 11. Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response.
    Penner JA.
    Haemophilia; 2001 Jan 10; 7(1):103-8. PubMed ID: 11136390
    [No Abstract] [Full Text] [Related]

  • 12. Switching haemophilia products and inhibitor risk: a United States' perspective.
    Nance D, Rodgers GM.
    Eur J Haematol; 2015 Apr 10; 94(4):283. PubMed ID: 25800968
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.
    Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, Vetter H, Brackmann HH.
    Blood; 2005 Mar 15; 105(6):2287-93. PubMed ID: 15542586
    [Abstract] [Full Text] [Related]

  • 14. Recombinant clotting factor concentrates.
    Lusher JM.
    Baillieres Clin Haematol; 1996 Jun 15; 9(2):291-303. PubMed ID: 8800506
    [No Abstract] [Full Text] [Related]

  • 15. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL.
    Haemostasis; 1992 Jun 15; 22(5):268-75. PubMed ID: 1478538
    [Abstract] [Full Text] [Related]

  • 16. Immunological aspects of inhibitor development.
    Reding MT.
    Haemophilia; 2006 Dec 15; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [Abstract] [Full Text] [Related]

  • 17. Recombinant clotting factors in the treatment of hemophilia.
    Lee C.
    Thromb Haemost; 1999 Aug 15; 82(2):516-24. PubMed ID: 10605745
    [No Abstract] [Full Text] [Related]

  • 18. Animal models of inhibitors.
    Reipert B, Arruda V, Lillicrap D.
    Haemophilia; 2010 Jul 15; 16 Suppl 5():47-53. PubMed ID: 20590856
    [Abstract] [Full Text] [Related]

  • 19. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
    DiMichele DM.
    Haemophilia; 2006 Dec 15; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
    [Abstract] [Full Text] [Related]

  • 20. Oral solutions.
    Dolgin E.
    Sci Am; 2015 Jan 15; 312(1):S12-3. PubMed ID: 25597119
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.